| 今开：1.56 | 昨收：1.58 |
| 最高：1.605 | 最低：1.52 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：7.5883573E7 |
Cue Biopharma(CUE)03-29 04:35
$Cue Biopharma(CUE)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0000950170-24-038084 Act: 33 Size: 146 KB 网页链接查看全文
Cue Biopharma(CUE)03-29 04:45
$Cue Biopharma(CUE)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000950170-24-038059 Act: 34 Size: 12 MB 网页链接查看全文
Cue Biopharma(CUE)03-09 05:05
$Cue生物制药(CUE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-028609 Size: 5 KB 网页链接查看全文
Cue Biopharma(CUE)03-09 05:05
$Cue生物制药(CUE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-028612 Size: 5 KB 网页链接查看全文
Cue Biopharma(CUE)03-09 05:05
$Cue生物制药(CUE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-028608 Size: 5 KB 网页链接查看全文
Cue Biopharma(CUE)03-12 06:45
$Cue生物制药(CUE)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001781002-24-000025 Act: 34 Size: 41 KB 网页链接查看全文
Cue Biopharma(CUE)03-09 05:05
$Cue生物制药(CUE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-028613 Size: 5 KB 网页链接查看全文
Cue Biopharma(CUE)03-09 05:05
$Cue生物制药(CUE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-028611 Size: 5 KB 网页链接查看全文
Cue Biopharma(CUE)02-23 05:05
$Cue生物制药(CUE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-018724 Size: 5 KB 网页链接查看全文
Cue Biopharma(CUE)02-08 06:15
$Cue生物制药(CUE)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001086364-24-006803 Act: 34 Size: 12 KB 网页链接查看全文
$Cue生物制药(CUE)$ 内部交易: 2019-12-23,Director,MARLETT CHRISTOPHER A ,卖出,17000普通股, $16.82
$Cue生物制药(CUE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-19-062031 Size: 8 KB 网页链接
$Cue生物制药(CUE)$ 内部交易: 2019-12-19,Director,MARLETT CHRISTOPHER A ,卖出,4000普通股, $17.00
$Cue生物制药(CUE)$ 内部交易: 2019-12-17,Director,MARLETT CHRISTOPHER A ,卖出,20732普通股, $15.73
$Cue生物制药(CUE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-19-061377 Size: 12 KB 网页链接
$Cue生物制药(CUE)$ SC 13D General statement of acquisition of beneficial ownership Accession Number: 0001493152-19-019389 Act: 34 Size: 67 KB 网页链接
$Cue生物制药(CUE)$ 8-K Current report, items 1.01, 1.02, and 9.01 Accession Number: 0001193125-19-300091 Act: 34 Size: 204 KB 网页链接
$Cue生物制药(CUE)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001193125-19-300046 Act: 33 Size: 672 KB 网页链接
$Cue生物制药(CUE)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001193125-19-289917 Act: 34 Size: 63 KB 网页链接
$Cue生物制药(CUE)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-11-07 AccNo: 0001564590-19-041703 Size: 5 MB 网页链接